Dr. Reddy's wins tentative FDA approval for twice-yearly HIV prevention injection
RDY•Dr. Reddy's received tentative U.S. FDA approval under PEPFAR for twice-yearly injectable lenacapavir for HIV prevention. The price is set at $40 per person annually across 120 countries outside the U.S., with initial supplies expected by the end of 2026 and broader availability in 2027.
